Race Executive Director on Disrupt Radio
Race Executive Director on Disrupt Radio
Race Oncology Executive Director Dr Peter Smith joined Disrupt Radio to discuss building biotech businesses in Australia, what to look out for when investing in biotech businesses, and why Race’s lead drug bisantrene is...
What’s In Store For 2024: Race Oncology
What’s In Store For 2024: Race Oncology
2024 Preview: Race Oncology (ASX:RAC) from Stockhead on Vimeo. Stockhead’s Ashtyn Hiron sits down with Race Oncology (ASX:RAC) CEO Daniel Tillett to close the books on 2023 and gain a sneak peek into what’s around the corner. The clinical stage...
